Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease

Published:2021-09-02 Issue:2 Volume:6 Page:309-319
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Arvind Ashwini¹²,Henson Jacqueline B.¹³^ORCID,Osganian Stephanie A.²,Nath Cheryl²,Steinhagen Lara M.²,Memel Zoe N.¹³,Donovan Arley²,Balogun Oluwafemi²,Chung Raymond T.¹²⁴,Simon Tracey G.¹²⁴^ORCID,Corey Kathleen E.¹²⁴

Affiliation:

1. Harvard Medical School Boston MA USA

2. Liver Center and Gastrointestinal Division Massachusetts General Hospital Boston MA USA

3. Department of Medicine Massachusetts General Hospital Boston MA USA

4. Clinical and Translational Epidemiology Unit Massachusetts General Hospital Boston MA USA

Funder

Harvard University Center for AIDS Research

Massachusetts General Hospital

American Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1818

Reference28 articles.

1. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

2. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

3. Health and economic burden of nonalcoholic fatty liver disease in the United States and its impact on veterans;Shetty A;Fed Pract,2019

4. Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease

5. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysfunctional VLDL metabolism in MASLD;npj Metabolic Health and Disease;2024-07-22

2. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge;Metabolism and Target Organ Damage;2024-06-26

3. Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis;Current Problems in Cardiology;2024-06

4. Mediating effect of diabetes on the relationship between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease: a prospective cohort study;European Journal of Gastroenterology & Hepatology;2024-05-20

5. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis;Annals of Hepatology;2024-05